Health Exec: Food-as-Medicine Will Change How Healthcare Is Delivered With or Without GLP-1s
During a panel discussion on GLP-1s at the Abarca Forward conference, one health executive stressed the importance of a food-as-medicine approach.
Challenges and opportunities in FDA’s new digital health regulations
A range of companies at the Digital Health showcase in San Francisco discussed how they view the changing regulatory environment within the category of software as a medical device.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Digital health companies highlight value of rigorous validation
At Health Datapalooza this week, Akili Interactive Labs and WellDoc officers talked about validating their "software as a drug" products.
WellDoc raises $22M to accelerate adoption of Type 2 diabetes prescription app
BlueStar requires a prescription from a licensed healthcare provider and can be reimbursed by health plans.
Biotech veteran comes to mhealth market as WellDoc president
Mhealth apps developer WellDoc has tapped the biotech industry for a new president as it prepares to roll out its BlueStar platform — its FDA-cleared mobile health app to improve patient engagement for people with Type 2 diabetes, according to a company statement. The move to hire Kevin McRaith illustrates the narrowing connections between pharmaceutical […]
WellDoc attracts funding from Merck’s investment arm as part of $20M strategic financing
In the run-up to WellDoc’s commercial launch of its mobile health prescription app for Type 2 diabetes, it has focused exclusively on angel investors for fundraising. In a shift from that strategy, it has attracted investment from two institutional investors in a $20 million strategic financing deal, according to a company statement. It tapped Merck’s […]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
WellDoc developing mhealth tool to predict hypoglycemia
Type 2 diabetes is viewed as one of the biggest drivers of healthcare costs partly because of the complications that can arise from the condition. Diabetes costs in 2012, for example, reached $245 billion. One complication — hypoglycemia — can cause diabetic coma if it remains untreated. WellDoc is working on a way to predict […]
WellDoc readies prescription mobile health app for type2 diabetes
WellDoc is gearing up to launch a doctor-prescribed mobile health app for type 2 diabetes next year, a milestone for how apps are perceived by the medical industry and will be used in the future. In an interview with MedCity News, WellDoc chief strategy and commercial officer Chris Bergstrom said it would be launching its […]
8 things mobile health entrepreneurs should know
At the mobile health technology conference mHealthcon held at Rutgers University on Dec. 1, one panel shared some interesting insights about their businesses and what entrepreneurs and adapters of mobile health technology could learn from them. Patients are consumers first. The users of your product may be patients, but they evaluate new product choices the […]